¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"multiple system atrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® atrophy ÇÑ±Û À§Ãà(Áõ)
¼³¸í   
  Á¶Á÷À̳ª ¼¼Æ÷ È¤Àº ±â°üÀÇ Å©±â°¡ ¿ø·¡ÀÇ Å©±â¿¡ ºñÇÏ¿© ÁÙ¾îµå´Â °ÍÀ» ÀÏÄ´ ¸». Ã³À½ºÎÅÍ Å©±â°¡ ÀÛÀº ¹«Çü¼º/Çü¼ºÀúÇÏÁõ(aplasia/hypoplasia)¿Í ±¸º°µÈ´Ù.
¿µ¹® multiple sclerosis ÇÑ±Û ´Ù¹ß°æÈ­Áõ
¼³¸í   
  ½Å°æÃà»èÀ» µÑ·¯½Î°í Àִ ¸»ÀÌÁý(myelin sheath)ÀÇ ÆÄ±«·Î ÀÎÇÑ º´Àû»óŸ¦ ¸»ÇÔ. ÆÄ±«µÈ ¸»ÀÌÁýÀº ÈäÅ͸¦ ³²±â°Ô µÇ¾î ½Å°æÃà»èÀ» ÅëÇÑ ½Å°æÀü´ÞÀÌ Á¦´ë·Î µÇÁö ¾Ê¾Æ ¿îµ¿, °¨°¢, ÀÚÀ²½Å°æ ¸ðµÎÀÇ ½Å°æÀü´ÞÀå¾Ö°¡ ³ªÅ¸³­´Ù. ÀÌ º´Åʹ ¾îµð¼­³ª ³ªÅ¸³¯ ¼ö À־ ±× Àå¾Ö°¡ ³ªÅ¸³ª´Â ºÎÀ§¿¡ µû¶ó ¼­·Î ´Ù¸¥ Áõ»óÀ» È£¼ÒÇÑ´Ù.
¿µ¹® multiple myeloma ÇÑ±Û ´Ù¹ß°ñ¼öÁ¾
¼³¸í   
  ´Ù¹ß¼º ¿ø¹ß¼º°ñÁ¾¾ç. ¸Ó¸®»À-°¥ºñ»À-º¹Àå»À-ôÃß»À-°ñ¹Ý µî¿¡ Àß ³ªÅ¸³ª°í, ¹°··¹°··ÇÑ Á¾±«¸¦ Çü¼ºÇϸç, »ÀÀÇ Èí¼ö°¡ ÀϾ°í, 40~60¼¼ ³²ÀÚ¿¡°Ô ¸¹ÀÌ ¹ß»ýÇÑ´Ù. °ñ¼öÁ¾ Á¾¾ç¼¼Æ÷´Â ÇüÁú¼¼Æ÷¿¡¼­ À¯·¡ÇÑ °ÍÀ̾ ÇüÁú¼¼Æ÷Á¾À̶ó°íµµ ÇÑ´Ù. °ú°Å¿¡´Â ÇüÁú¼¼Æ÷¼º°ñ¼öÁ¾ À̿ܿ¡´Â ´Ù¸¥ °ñ¼öÁ¶Ç÷¿ä¼Ò¿¡¼­ »ý±â´Â °ñ¼öÁ¾À̶ó°í »ý°¢ÇßÁö¸¸ ÇöÀç´Â ºÎÁ¤µÇ°í ÀÖ´Ù. ÇüÁú¼¼Æ÷´Â ¿ø·¡ ¸é¿ª±Û·ÎºÒ¸°À» »ý»êÇϴ ¼¼Æ÷À̸ç, ±×°ÍÀÌ Á¾¾çÈ­ÇÑ ´Ù¹ß °ñ¼öÁ¾ È¯ÀÚ¿¡¼­µµ ´ëºÎºÐ Ç÷û ¼Ó¿¡ ¸é¿ª ±Û·ÎºÒ¸°ÀÌ Áõ°¡µÈ °ÍÀ» º¼ ¼ö ÀÖ´Ù. Áõ°¡ÇÑ ±Û·ÎºÒ¸°Àº IgG³ª IgAÀΠ°æ¿ì°¡ ¸¹Áö¸¸ ´Ù¸¥ Çüµµ ÀÖ´Ù. °ñ¼öÁ¾ È¯ÀÚ ¾à 50%´Â ¿ÀÁÜ¿¡¼­ º¥½ºÁÔ½º´Ü¹éÁúÀÌ °ËÃâµÇ´Âµ¥, ÀÌ ´Ü¹éÁúÀÇ ÃàÀû¿¡ ÀÇÇØ ¿ä¼¼°üÀÌ ÆÄ±«µÇ°í, ÄáÆÏ°æÈ­°¡ ÀϾ´Ù. °ñ¼öÁ¾ È¯ÀÚ¿¡¼­´Â Ç÷û´Ü¹é ÀÌ»óÀ¸·Î °¡²û ¾Æ¹Ð·ÎÀ̵åÁõÀÌ ³ªÅ¸³­´Ù. »À X¼± ¼Ò°ßÀ¸·Î¼­´Â µµ·Á³½ º´ÅÍ, °ñÀ¶ÇØ»ó, º´Àû°ñÀýÀÌ °üÂûµÈ´Ù.
¿µ¹® multiple personality ÇÑ±Û ´ÙÀμº ÀΰÝ
¼³¸í   
  Çظ®¼º Á¤½ÅÀå¾ÖÀÇ Çϳª·Î ³ªÅ¸³­´Ù. ÇÑ »ç¶÷ÀÌ ¿©·¯ »ç¶÷ÀÇ ¼º°ÝÀ» ¼ÒÀ¯Çϰí Àִ °ÍÀ¸·Î ¸¶Ä¡ ¡°Áöų¹Ú»ç¿Í ÇÏÀ̵堾¾¡±¿Í °°Àº °æ¿ìÀÌ´Ù. ¾Æ¸¶, ÇöÀç ÀÚ½ÅÀǠóÁö¿¡¼­ ¹þ¾î³ª°í ½ÍÀº ¹«ÀǽÄÀûÀΠ¿å¸Á¿¡¼­ ºñ·ÔµÇ´Â °ÍÀ¸·Î ¿©°ÜÁø´Ù.
¿µ¹® hepatic portal system ÇÑ±Û °£¹®¸Æ°è
¼³¸í   
  À§, ÀÛÀºÃ¢ÀÚÀ̳ª Å«Ã¢ÀÚ¿¡¼­ ¿µ¾çºÐÀ» Èí¼öÇϱâ À§ÇÑ ¸ð¼¼Ç÷°üÁ¶Á÷Àº ¸ðµÎ °£À¸·Î ¿¬°áµÈ´Ù. Áï ¼ÒÈ­±â¿¡ Èí¼öÇÑ ¿µ¾çºÐÀÌ °¡µæÇÑ ÇǴ ¸ðµÎ °£À¸·Î ¿¬°áµÇ´Âµ¥ À̰ÍÀ» ¹®¸Æ°è¶ó°í ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • atrophy
    À§Ãà(Áõ)
  • alveolar atrophy
    ÀÌÆ²À§Ãà, Ä¡Á¶À§Ãà
  • back pressure renal atrophy
    ¿ª¾ÐÄáÆÏÀ§Ãà, ¿ª¾Ð½ÅÀåÀ§Ãà
  • correlated atrophy
    »ó°üÀ§Ãà
  • cortical atrophy
    °ÑÁúÀ§Ãà, ÇÇÁúÀ§Ãà
  • choroidal atrophy
    ¸Æ¶ô¸·À§Ãà
  • cicatrical atrophy
    ÈäÅÍÀ§Ãà
  • denervation atrophy
    Å»½Å°æÀ§Ãà
  • disuse atrophy
    ºÒ»ç¿ëÀ§Ãà
  • eccentric atrophy
    Æí½ÉÀ§Ãà
  • facial atrophy
    ¾ó±¼À§Ãà, ¾È¸éÀ§Ãà
  • fat atrophy
    Áö¹æÀ§Ãà
  • geographic atrophy
    Áöµµ¸ð¾çÀ§Ãà
  • geographic retinal atrophy
    Áöµµ¸ð¾ç¸Á¸·À§Ãà
  • juvenile spinal muscular atrophy
    ¼Ò¾ÆÃ´¼ö±Ù(À°)À§ÃàÁõ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • atrophy
    ˤ̈
  • choroidal atrophy
    ¸Æ¶ô¸·À§Ãà, ¾ôÈû¸·À§Ãà
  • optic atrophy
    ½Ã°¢½Å°æÀ§Ãà
  • optic nerve atrophy
    (¢¡optic atrophy) ½Ã°¢½Å°æÀ§Ãà
  • spinal muscular atrophy
    ô¼ö±ÙÀ°À§Ãà(Áõ)
  • thenar atrophy
    ¾öÁöµÎµ¢À§Ãà
  • multiple birth
    ´Ù»ê, ´ÙÅÂÃâ»ê
  • plural multiple birth
    ´Ù»ê, ´ÙÅÂÃâ»ê
  • multiple
    ´Ù¹ß-, ¿©·¯-, ¹µ-, ´Ù-
  • multiple myeloma
    ´Ù¹ß°ñ¼öÁ¾
  • multiple endocrine neoplasia
    º¹ÇÕ³»ºÐºñ»ù½Å»ý¹°
  • multiple sclerosis
    ´Ù¹ß°æÈ­Áõ
  • multiple causation theory
    Áúº´¹ß»ý´Ù¿äÀμ³
  • system analysis
    °èÅëºÐ¼®
  • system
    1.°è, °èÅë, ü°è, 2.ÀåÄ¡, 3.Á¦µµ,
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • atrophy
    ˤ̈
  • alveolar atrophy
    ÀÌÆ²À§Ãà, Ä¡Á¶À§Ãà
  • back pressure renal atrophy
    ¿ª¾ÐÄáÆÏÀ§Ãà, ¿ª¾Ð½ÅÀ§Ãà
  • cicatrical atrophy
    ÈäÅÍÀ§Ãà
  • correlated atrophy
    »ó°üÀ§Ãà
  • cortical atrophy
    °ÑÁúÀ§Ãà
  • cyanotic atrophy
    û»öÁõÀ§Ãà
  • denervation atrophy
    Å»½Å°æÀ§Ãà
  • disuse atrophy
    ºÒ»ç¿ëÀ§Ãà
  • eccentric atrophy
    Æí½ÉÀ§Ãà
  • facial atrophy
    ¾ó±¼À§Ãà, ¾È¸éÀ§Ãà
  • fat atrophy
    Áö¹æÀ§Ãà
  • geographic atrophy
    ÁöµµÇüÀ§Ãà
  • halisteretic atrophy
    ŻȸÀ§Ãà
  • lactation atrophy
    ¼öÀ¯À§Ãà, Á¥ºÐºñÀ§Ãà
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Cowdens syndrome = multiple hamartoma syndrome
    ´Ù¹ß¼º °ú¿ÀÁ¾ ÁõÈıº
  • MOTSA (multiple overlapping thin-slab acquisition)
    ´ÙÁß Áߺ¹ ¼¼ÆíÆÇ ȹµæ
  • infection, multiple
    ´ÙÁß°¨¿°, º¹¼ö±Õ°¨¿°
  • infectious multiple gangrene of skin
    Àü¿°¼º ÇǺΠ´Ù¹ß¼º ±«Àú
  • personality disorder, multiple
    ´ÙÁß(Òýñì) ÀΰÝÀå¾Ö
  • personality, multiple
    ´ÙÁßÀΰÝ.
  • plural birth =multiple b.
    ´Ùźи¸(Òý÷à ÝÂØ´).
  • T-tubular system =>transverse tubular system
    T-°è, °¡·Î¼Ò°ü °èÅë
  • Sudecks atrophy
    ¼öµ¦ À§Ãà
  • acute yellow atrophy
    ±Þ¼º Ȳ»öÀ§Ãà(Áõ)(ÐáàõüÜßäê×õêñø) °£(ÊÜ)ÀÇ .
  • acute yellow atrophy
    ±Þ¼º Ȳ»öÀ§Ãà(Áõ)(ÐáàõüÜßäê×õêñø) °£(ÊÜ)
  • alveolar atrophy<³ª> atrophia alveolaris
    Ä¡Á¶À§Ãà(öÍðËê×õê).
  • gastric atrophy
    À§¼±À§Ãà(êÖàÍê×õê).
  • gastric mucosa atrophy
    À§Á¡¸·À§Ãà.
  • geographic atrophy
    ÁöµµÇüÀ§Ãà
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transverse tubular system =T system
    ÀÌ ·Î¼Ò°ü°èÅë, T°è(¡­Í§), ȾÇà¼Ò°ü°è(üôú¼á³Î·Í§) ±Ù(ÐÉ)ÀÇ .
  • acute yellow atrophy
    ±Þ¼º Ȳ»öÀ§Ãà(Áõ)(ÐáàõüÜßäê×õêñø) °£(ÊÜ)
  • acute yellow atrophy
    ±Þ¼º Ȳ»öÀ§Ãà(Áõ)(ÐáàõüÜßäê×õêñø) °£(ÊÜ)ÀÇ .
  • alveolar atrophy<³ª> atrophia alveolaris
    Ä¡Á¶À§Ãà(öÍðËê×õê).
  • atrophy
    ˤ̈
  • atrophy from disuse =disuse a.
    ºñȰµ¿(¼º)À§Ãà, ¹«À§(ÙíêÓ)À§Ãà.
  • atrophy noir
    Èæ»öÀ§Ãà
  • atrophy, brown
    À§Ãà(¡­), °¥»ö
  • atrophy<³ª> atrophia, ºÒ atrophie
    À§Ãà(Áõ)(ê×õêñø), ¹«¿µ¾çÁõ(Ùíç½å×ñø)
  • back pressure renal atrophy
    ¿ª¾Ð¼º ½ÅÀ§Ãà
  • blue atrophy
    û»öÀ§Ãà(ôìßäê×õê).
  • bone atrophy
    °ñ À§Ãà(Íéê×õê).
  • brown atrophy
    °¥»öÀ§Ãà(Êèßäê×õê)
  • cavernous optic atrophy
    ÇØ¸é½Ã½Å°æÀ§Ãà
  • cell,atrophy
    À§Ãà (ê×õê)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Multiple placenta
    ¹µÅ¹Ý
    [¿¾ ¿ë¾î] ´Ù¹ß¼ºÅ¹Ý
  • Multiple deformity
    º¹ÇÕ±âÇü
    [¿¾ ¿ë¾î] ´Ù¹ß¼º±âÇü
  • Multiple morphologic defect
    º¹ÇÕÇüŰáÇÔ
    [¿¾ ¿ë¾î] ´Ù¹ß¼ºÇüÅÂÇÐÀû°áÇÔ
  • Fornical system
    ³úȰ°èÅë
    [¿¾ ¿ë¾î] ³ú±Ã°è
  • Glial cell of peripheral nervous system
    ¸»ÃʾƱ³¼¼Æ÷
    [¿¾ ¿ë¾î] ¸»Ãʱ³¼¼Æ÷
  • Osteon [Harversian system]
    »À´ÜÀ§
    [¿¾ ¿ë¾î] °ñ¿ø
  • Genital system
    »ý½Ä°èÅë
    [¿¾ ¿ë¾î] »ý½Ä±â°èÅë
  • Cardiac conducting system
    ½ÉÀåÀüµµ°èÅë
    [¿¾ ¿ë¾î] ½ÉÀåÀÚ±ØÀüµµ°è
  • Conduction system of heart
    ½ÉÀåÀüµµ°èÅë
    [¿¾ ¿ë¾î] ½ÉÀåÀüµµ°è
  • CENTRAL NERVOUS SYSTEM
    ÁßÃ߽Űæ°èÅë
    [¿¾ ¿ë¾î] ÁßÃ߽Űæ°è
  • Glial cell of central nervous system
    ÁßÃ߾Ʊ³¼¼Æ÷
    [¿¾ ¿ë¾î] ÁßÃß±³¼¼Æ÷
  • Renal system
    ÄáÆÏ°èÅë
    [¿¾ ¿ë¾î] ½ÅÀå°èÅë
  • Primitive duct system
    ¿ø½Ã°ü°èÅë
    [¿¾ ¿ë¾î] ¿ø½Ã°ü°èÅë
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • multiple budding
    ´Ù¼öÃâ¾Æ
  • multiple fission
    ´ÙºÐ¿­
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • atrophy
    À§Ãà (ê×õê)
  • multiple alleles
    º¹´ë¸³À¯ÀüÀÚ(ÜÜÓߨ¡ë¶îîí­)
  • multiple binding
    ´ÙÁß°áÇÕ(ÒýñëÌ¿ùê)
  • multiple codon recognition
    ´Ù(Òý)ÄÚµ· ÀÎÁö(ìãò±)
  • multiple displacement mechanism
    ´Ù(Òý)´ëü(ÓÛôð) ±âÀü(Ѧï®)
  • multiple factor hypothesis
    ´ÙÀÎÀÚ¼³(Òýì×í­àã)
  • multiple gene
    ´ÙÀ¯ÀüÀÚ(Òýë¶îîí­)
  • multiple inhibition analysis
    ´ÙÁß(Òýñì)ÀúÇØ ºÐ¼®(îÁúªÝÂà°)
  • ABO blood group (type) system
    ABOÇ÷¾×Çü (úìäûúþ) ½Ã½ºÅÛ
  • absorption optical system
    Èí¼ö(ýåâ¥) ±¤ÇÐ(ÎÃùÊ) ½Ã½ºÅÛ
  • adiabatic system
    ´Ü¿­(Ó¨æð)½Ã½ºÅÛ
  • ATP regeneration system
    ATPÀç»ý(î¢ßæ) ½Ã½ºÅÛ
  • binding protein transport system
    °áÇÕ ´Ü¹éÁú ¼ö¼Û(Ì¿ùêÓ±ÛÜòõâÃáê) ½Ã½ºÅÛ
  • brain barrier system
    ³úÀ庮(Òàî¡Ûú) ½Ã½ºÅÛ
  • cell-free amino acid incorporating system
    ¹«¼¼Æ÷(Ùíá¬øà) ¾Æ¹Ì³ë»ê ÆíÀÔ(øºìý)¾¾½ºÅÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • atrophy
    À§ÃàÁõ, ¹«¿µ¾çÁõ
  • denervation atrophy
    Å»½Å°æÀ§Ãà
  • muscle atrophy
    ±ÙÀ§Ãà
  • muscular atrophy
    ±ÙÀ§Ãà
  • neurogenic muscular atrophy
    ½Å°æ¼º±ÙÀ§Ãà(Áõ)
  • optic atrophy
    ½Ã½Å°æÀ§Ãà
  • optic nerve atrophy
    ½Ã½Å°æÀ§Ãà
  • senile atrophy
    ³ë³â(³ëÀÎ)¼ºÀ§Ãà
  • thenar atrophy
    ¹«Áö±¸À§Ãà
  • MOTSA [=multiple overlapping thin-slab acquisition]
    ´ÙÁßÁߺ¹¼¼ÆíÆÇȹµæ
  • multiple
    ´Ù¹ß¼º
  • multiple cranial nerve palsy
    ´Ù¹ß¼º³ú½Å°æ¸¶ºñ
  • multiple echo
    ´ÙÁß¿¡ÄÚ
  • multiple epiphyseal dysplasia
    ´Ù¹ß¼º°ñ´ÜÀÌÇü¼ºÁõ
  • multiple excitaiton
    ´ÙÁß¿©±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
MCS malignant carcinoid syndrome; managed care system; massage of the carotid sinus; mesocaval shunt; me...
MSA major serologic antigen; male-specific antigen; mannitol salt agar; Medical Services Administration;...
ISIS image selected in vivo spectroscopy; imaging science and information system; information system-imag...
SMA sequential multiple analysis or analyzer; sequential multichannel autoanalyzer; simultaneous multich...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MSA Multiple System Atrophy
MOSF Multiple Organ System Failure
MSOF Multiple System Organ Failure
T system tubular system
CA Cerebellar atrophy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • multiple fission,multiple division
    ´Ù ºÐ¿­
    1°³ÀÇ ¸ð¼¼Æ÷°¡ ÀϽÃÀûÀ¸·Î ´Ù¼öÀÇ µþ ¼¼Æ÷·Î ³ª´©¾îÁö´Â ÀÏ. º¹ ºÐ¿­À̶ó°íµµ ÇÑ´Ù. ¸ðü°¡ 2°³ÀÇ µþ °³Ã¼·Î ³ª´©¾îÁö´Â 2ºÐ¿­¿¡ ´ëÇÏ¿© ÀϽÿ¡ ´Ù¼öÀÇ µþ °³Ã¼·Î ºÐ¿­ÇÏ´Â Çö»óÀ» ¸»ÇÑ´Ù. ¿ø»ýµ¿¹° Æ÷ÀÚÃæ·ùÀÇ Áõ¿ø»ý½Ä µî¿¡¼­ º¼ ¼ö ÀÖ´Ù. Áï, ÇÙ¸¸ÀÌ ºÐ¿­À» µÇÇ®ÀÌÇÏ¿© ´ÙÇÙü°¡ µÈ µÚ¿¡ ¼¼Æ÷ÁúÀÌ ÀÏÁ¦È÷ ºÐ¿­ÇÏ¿© °¢°¢ ÇÙ 1°³¾¿À» ÇÔÀ¯ÇÏ´Â µþ °³Ã¼·Î ³ª´©¾îÁø´Ù.
  • affecting multiple system
    ´Ù¹ß¼º °èÅëÀ» ħ¹üÇÑ
  • age atrophy
    ³ëÀμº ÅðÃà
    ³ªÀ̰¡ µê¿¡ µû¸¥ ¸ðµç Á¶Á÷ÀÇ »ý¸®ÀûÀÎ °¨¼Ò.
  • alveolar atrophy
    Ä¡Á¶ À§Ãà
  • atrophy
    À§Ãà, À§ÃàÁõ, ¹«¿µ¾çÁõ
    ¹Ý´ë¾î=hy
  • atrophy from disuse
    ºñȰµ¿ À§Ãà, ºñȰµ¿¼º À§Ãà, ¹«À§ À§Ãà
    µ¿ÀǾî=disuse atro
  • atrophy noir
    Èæ»ö À§Ãà
  • correlated atrophy
    »ó°ü À§Ãà, »ó°ü À§ÃàÁõ
  • dental atrophy
    Ä¡¾Æ À§Ãà
    Ä¡¾ÆÀÇ ¿ÜÇüÀÌ Á¤»ó »óź¸´Ù ÁÙ¾îµç °Í.
  • dentate cerebellar atrophy
    Ä¡»ó ÇÙ ¼Ò³ú À§Ãà
    ¼Ò³úÀÇ Ä¡»ó ÇÙÀÌ ÁÙ¾îµå´Â º´¼Ò.
  • diffuse atrophy of alveolar bone
    ¹Ì¸¸¼º Ä¡Á¶°ñ À§Ãà
  • disuse muscle atrophy
    ±ÙÆó¿ë À§Ãà
    ±Ù À§ÃàÀº ¿©·¯ °¡ÁöÀÇ ½Å°æ, ±Ù ÁúȯÀÇ ÁÖ¿ä Áõ»óÀ¸·Î¼­ Áß¿äÇѵ¥ ÀÌ¿Í °°Àº Å»½Å°æ¿¡ ÀÇÇÑ ±Ù À§Ãà À̿ܿ¡µµ ¾ÈÁ¤¿Í»óÀ̳ª °üÀý °íÁ¤ µî¿¡ ÀÇÇÑ ºÎµ¿À¸·Î ¹ß»ýÇÏ´Â ±Ù À§ÃàÀÌ ÀÖ°í ÀüÀÚ¿¡ ¸øÁö ¾Ê°Ô Áß¿äÇÏ´Ù. À̰ÍÀ» Æó¿ë¼º ±Ù À§ÃàÀ̶ó°í ÇÑ´Ù. Àå±â¿Í»ó ȯÀÚ¿¡°Ô À־´Â »óÁö¿¡ ºñÇØ¼­ ÇÏÁöÀÇ ±Ù À§ÃàÀÌ µÎµå·¯Áö°í ÀÌ·± °æÇâÀº °í·ÉÀÚ¿¡°Ô ƯÈ÷ ÇöÀúÇÏ´Ù. ü¿ë¼º ±Ù À§ÃàÀÇ ¹ß»ýÀÌ ¿¹»óµÇ´Â °æ¿ì¿¡´Â ¿¹¹æÀ» À§ÇÑ ±Ù·Â À¯Áö Áõ°­ ÈÆ·ÃÀÌ ÀÌ·ç¾îÁ®¾ß ÇÏ°í ¶Ç Á¶±â ÀÌ»ó, Á¶±â º¸ÇàÀÌ ¸ðµç Áúȯ¿¡¼­ ÃßÁøµÉ Çʿ䰡 ÀÖ´Ù.
  • eccentric atrophy
    ¿ø½É¼º À§Ãà
  • facial atrophy
    ¾È¸é À§Ãà
  • facioscapulohumeral atrophy
    ¾È¸é °ß°© »ó¿Ï À§Ãà, ¾È¸é °ß°© »ó¿Ï±Ù À§Ãà, ¾È¸é °ß°© »ó¿Ï±Ù À§ÃàÁõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
multiple system atrophy A name grouping together the four cerebral degenerative diseases of olivopontocerebellar atrophy, shy-drager syndrome, striatonigral degeneration, and one form of parkinson disease, considering them different forms of the same disease process.
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
abortion, multiple Couples who have had 2 or more miscarriages (spontaneous abortions) have about a 5% chance that one member of the couple is carrying a chromsome translocation responsible for the miscarriages.
(12 Dec 1998)
advanced multiple-beam equalization radiography A variant of scanning equalization radiography using several X-ray beams.
(05 Mar 2000)
amyloidosis of multiple myeloma Foci of amyloidosis in mesenchymal tissues of some persons with multiple myeloma; no direct relation between amyloid and Bence Jones protein is conclusively known.
(05 Mar 2000)
cancer, multiple myeloma A bone marrow cancer involving a type of white blood cell called a plasma (or myeloma) cell. The tumour cells can form a single collection (a plasmacytoma) or many tumours (multiple myeloma). Plasma cells are part of the immune system and make antibodies. Because patients have an excess of identical plasma cells, they have too much of one type of antibody. As myeloma cells increase in number, they damage and weaken the bones, causing pain and often fractures. When bones are damaged, calcium is released into the blood leading to hypercalcaemia (excess calcium in the blood) and that causes loss of appetite, nausea, thirst, fatigue, muscle weakness, restlessness, and confusion. Myeloma cells prevent the bone marrow from forming normal plasma cells and other white blood cells important to the immune system so patients may not be able to fight infections. The cancer cells can also prevent the growth of new red blood cells, causing anaemia. Excess antibody proteins and calcium may prevent the kidneys from filtering and cleaning the blood properly Cancer, non-Hodgkin's lymphoma: A lymphoma is a cancer that develops in the lymphatic system. The most common symptom of non-Hodgkin's lymphomas is a painless swelling in the lymph nodes in the neck, underarm, or groin. Non-Hodgkin's lymphomas are diagnosed with a biopsy of an enlarged lymph node. Follow-up examinations are important after lymphoma treatment. Most relapses occur in the first 2 years after therapy.
(12 Dec 1998)
chromosomes in multiple miscarriages Couples who have had more than one miscarriage (spontaneous abortion) have about a 5% chance that one member of the couple is carrying a chromsome translocation responsible for the miscarriages.
(12 Dec 1998)
miscarriages, multiple, chromosomes in Couples who have had more than one miscarriage have about a 5% chance that one member of the couple is carrying a chromsome translocation responsible for the miscarriages.
(12 Dec 1998)
multiple Manifold, occurring in or affecting various parts of the body at once.
Origin: L. Multiplex
(18 Nov 1997)
multiple alcohol An alcohol containing more than one OH group.
(05 Mar 2000)
multiple amputation Amputation of two or more limbs or parts of limbs performed at the same operation.
(05 Mar 2000)
multiple anchorage Anchorage in which more than one type of resistance unit is utilised.
Synonym: reinforced anchorage.
(05 Mar 2000)
multiple birth offspring The offspring in multiple pregnancies (pregnancy, multiple): twins, triplets, quadruplets, quintuplets, etc.
(12 Dec 1998)
multiple carboxylase deficiency Abnormalities in carbohydrate and branched-chain amino acid catabolism that are responsive to biotin therapy. It may be due to deficiency of propionyl-CoA carboxylase, methylcrotonyl-CoA carboxylase, biotinidase, or propionyl-CoA carboxylase, methylcrotonyl-CoA carboxylase, and pyruvate carboxylase.
(12 Dec 1998)
multiple chemical sensitivity An acquired disorder characterised by recurrent symptoms, referable to multiple organ systems, occurring in response to demonstrable exposure to many chemically unrelated compounds at doses far below those established in the general population to cause harmful effects. No single widely accepted test of physiologic function can be shown to correlate with symptoms. (cullen mr. The worker with multiple chemical sensitivities: an overview. Occup med 1987;2(4):655-61)
(12 Dec 1998)
multiple cloning site Region of a phage or plasmid vector that has been engineered to contain a series of restriction sites that are usually unique within the entire vector. This makes it particularly easy to insert or excise (subclone) DNA fragments.
(18 Nov 1997)
multiple drug resistant tuberculosis A strain of TB that does not respond to two or more standard anti-TB drugs. MDR-TB usually occurs when treatment is interrupted thus allowing mutations in the organism to occur that confer drug resistance.
(09 Oct 1997)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Multiple System Atrophy - »õâ A syndrome complex composed of three conditions which represent clinical variants of the same disease process: STRIATONIGRAL DEGENERATION; SHY-DRAGER SYNDROME; and the sporadic form of OLIVOPONTOCEREBELLAR ATROPHIES. Clinical features include autonomic, cerebellar, and basal ganglia dysfunction. Pathologic examination reveals atrophy of the basal ganglia, cerebellum, pons, and medulla, with prominent loss of autonomic neurons in the brain stem and spinal cord. (From Adams et al., Principles of Neurology, 6th ed, p1076; Baillieres Clin Neurol 1997 Apr;6(1):187-204; Med Clin North Am 1999 Mar;83(2):381-92)
    Synonyms : Multiple System Atrophy Syndrome, Multisystem Atrophy, Multisystemic Atrophy, Atrophies, Multisystem, Atrophies, Multisystemic, Atrophy, Multiple System, Atrophy, Multisystem, Atrophy, Multisystemic, Multiple System Atrophies, Multisystem Atrophies
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 1 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
multiple system atrophy A degenerative condition characterized by low blood pressure when standing. It may lead to parkinsonism, rigidity, ataxia, fainting, or incontinence.
Ãâó: www.michaeljfox.org/parkinsons/glossary.php
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • atrophy
    À§Ãà; ¼è¾à
  • atrophy
    ¼è¾à;¼è¾àÇÏ´Ù;À§ÃàÇÏ´Ù
  • common multiple
    °ø¹è¼ö
  • multiple
    º¹ÇÕÀÇ;´Ù¾çÇÑ;¹è¼öÀÇ;¹è¼ö;¹è¼ö·®(least common multiple ÃÖ¼Ò °ø¹è¼ö)
  • multiple choice test
    ¼±´ÙÇü Å×½ºÆ®
  • multiple cropping
    ´Ù¸ðÀÛ
  • multiple farming
    ´Ù°¢ ³ó¾÷
  • multiple shop
    ¿¬¼âÁ¡
  • system
    Á¶Á÷,°èÅë,¹æ½Ä
  • Bertillon system
    º£¸£Æ¼¿ë½Ä ¹üÀνĺ°¹ý(Áö¹®À» Áß½Ã)
  • CAPTAIN System
    ĸƾ½Ã½ºÅÛ(°¡Á¤ÀÇ À¯¼± ÅÚ·¹ºñÀü¿¡ÀÇ Á¤º¸ Á¦°ø ½Ã½ºÃÀ,»óÇ¥¸í)
  • Continental System
    ´ë·úºÀ¼â(1806³â NapoleonÀÇ ¿µ±¹¿¡ ´ëÇÑ)
  • Copernican system
    ÄÚÆä¸£´ÏÄí½º¼³(ü°è);(žçÁ߽ɼ³,Áöµ¿¼³)
  • Dewey classification system
    µµ¼­ÀÇ µàÀÌ 10Áø ºÐ·ù¹ý
  • Dolby system
    µ¹ºñ¹æ½Ä(³ìÀ½ Å×ÀÌÇÁÀÇ ÀâÀ½À» ÁÙÀÌ´Â ¹æ¹ý)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á